trial

Clinical Risk State for Bipolar Disorder in Adolescents

NCTId NCT01383915
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Unknown
Enrollment 402 (estimated)
Sponsored by Northwell Health, Early Treatment Program at Lenox Hill
Primary completion 2023-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
402 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2009-09
Primary completion
2023-12-31
Eligibility
ALL · 12 Years · 18 Years

Interventions & indications

Drugs
—

Sponsors

Northwell Health, Early Treatment Program at Lenox HillLead Sponsor

Investigators

1
Christoph U. Correll, MDPrincipal Investigator

Sites

1 total
Glen Oaks, United States

Facts & assertions

4 sourced
Enrollment
402
Phase
NA
Primary Completion Date
2023-12-31
Status
UNKNOWN
relationships
The graph out of here
lead_sponsor
Northwell Health, Early Treatment Program at Lenox Hill
company
indication
Schizophrenia
indication
Bipolar Disorder
indication
Bipolar Disorder
indication
investigator
Christoph U. Correll, MD
person